Clinical trials
Phase 1/2 Recurrence trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 7 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 49 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 3 |
| Sun Yat-sen University | 3 |
| The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 3 |
| Huiqiang Huang | 2 |
| All India Institute of Medical Sciences | 1 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 1 |
| Centaurus Biopharma Co., Ltd. | 1 |
| Cyclacel Pharmaceuticals, Inc. | 1 |
| Gruppo Italiano Studio Linfomi | 1 |
| Han weidong | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 49 |
| Leukemia, Myeloid, Acute | 8 |
| Burkitt Lymphoma | 5 |
| Lymphoma | 5 |
| Lymphoma, B-Cell | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Multiple Myeloma | 4 |
| Lymphoma, Mantle-Cell | 3 |
| Hematologic Neoplasms | 2 |
| Hodgkin Disease | 2 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.